4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-002076
Director bought 300,000 shares at $21.00 ($6,300,000)
- Director acquired 7,613,887 shares (conversion)
- Director acquired 281,268 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GADICKE ANSBERT Director | 2021-01-07 | Other acquisition | +281,268 | 281,268 | D: show line 1 in the form | ||
| GADICKE ANSBERT Director | 2021-01-12 | Conversion | +1,136,525 | 1,136,525 | I: show line 2 in the form | ||
| GADICKE ANSBERT Director | 2021-01-12 | Conversion | +3,551,640 | 4,688,165 | I: show line 3 in the form | ||
| GADICKE ANSBERT Director | 2021-01-12 | Conversion | +2,276,692 | 6,964,857 | I: show line 4 in the form | ||
| GADICKE ANSBERT Director | 2021-01-12 | Conversion | +649,030 | 7,613,887 | I: show line 5 in the form | ||
| GADICKE ANSBERT Director | 2021-01-12 | Purchase | +300,000 | $21.00 | $6,300,000 | 7,913,887 | I: show line 6 in the form |
| Open-market purchases · 300,000 sh · avg $21.00 · $6,300,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GADICKE ANSBERT Director | 2021-01-07 | Other acquisition · Series Seed Convertible Preferred Stock | +1,136,525 | 1,136,525 | I: show line 7 in the form | |||||
| GADICKE ANSBERT Director | 2021-01-07 | Other acquisition · Series A Convertible Preferred Stock | +3,551,640 | 3,551,640 | I: show line 8 in the form | |||||
| GADICKE ANSBERT Director | 2021-01-07 | Other acquisition · Series B Convertible Preferred Stock | +2,276,692 | 2,276,692 | I: show line 9 in the form | |||||
| GADICKE ANSBERT Director | 2021-01-07 | Other acquisition · Series C Convertible Preferred Stock | +649,030 | 649,030 | I: show line 10 in the form | |||||
| GADICKE ANSBERT Director | 2021-01-07 | Other acquisition · Stock Option (Right to Buy) | +262,114 | 262,114 | D: show line 11 in the form | |||||
| GADICKE ANSBERT Director | 2021-01-07 | Other acquisition · Stock Option (Right to Buy) | +88,824 | 88,824 | D: show line 12 in the form | |||||
| GADICKE ANSBERT Director | 2021-01-12 | Conversion · Series Seed Convertible Preferred Stock | −1,136,525 | 0 | I: show line 13 in the form | |||||
| GADICKE ANSBERT Director | 2021-01-12 | Conversion · Series A Convertible Preferred Stock | −3,551,640 | 0 | I: show line 14 in the form | |||||
| GADICKE ANSBERT Director | 2021-01-12 | Conversion · Series B Convertible Preferred Stock | −2,276,692 | 0 | I: show line 15 in the form | |||||
| GADICKE ANSBERT Director | 2021-01-12 | Conversion · Series C Convertible Preferred Stock | −649,030 | 0 | I: show line 16 in the form |
Loading xslF345X03/doc4.xml…